1-8 of 8
Keywords: Parkinson's disease
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Biosci Rep (2021) 41 (9): BSR20203672.
Published: 31 August 2021
...Rachael J. Chandler; Susanna Cogo; Patrick A. Lewis; Eva Kevei For decades, Parkinson’s disease (PD) cases have been genetically categorised into familial, when caused by mutations in single genes with a clear inheritance pattern in affected families, or idiopathic, in the absence of an evident...
Biosci Rep (2020) 40 (12): BSR20202921.
Published: 21 December 2020
...Kecheng Lei; Liwen Zhang; Yijing He; Hui Sun; Weifang Tong; Yichun Xu; Lingjing Jin Early stage diagnosis of Parkinson’s disease (PD) is challenging without significant motor symptoms. The identification of effective molecular biomarkers as a hematological indication of PD may help improve...
Includes: Supplementary data
Biosci Rep (2020) 40 (10): BSR20202225.
Published: 14 October 2020
...Evy Lobbestael; Chris Van den Haute; Francesca Macchi; Jean-Marc Taymans; Veerle Baekelandt Pathogenic mutations in the leucine-rich repeat kinase 2 (LRRK2) gene belong to the most common genetic causes of inherited Parkinson’s disease (PD) and variations in its locus increase the risk to develop...
Includes: Supplementary data
Biosci Rep (2020) 40 (6): BSR20191796.
Published: 25 June 2020
...Jiahui Liu; Hong Liu; Zhenxiang Zhao; Jianfeng Wang; Dandan Guo; Yiming Liu The present study aimed to identify the gene expression changes conferred by capsaicin in the cell model of 6-OHDA-induced Parkinson's disease, to disclose the molecular mechanism of action of capsaicin. We used capsaicin...
Biosci Rep (2015) 35 (5): e00254.
Published: 08 October 2015
... upon binding and hydrolysis of GTP, indicating significant mechanistic variations within this protein class. Mutations in the most prominent member of the Roco family of proteins, leucine-rich repeat (LRR) kinase 2 (LRRK2), are the most frequent cause of late-onset Parkinson's disease (PD). Using...
Includes: Supplementary data
Biosci Rep (2013) 33 (5): e00074.
Published: 22 October 2013
...Chi L. L. Pham; Roberto Cappai The deposition of α-syn (α-synuclein) as amyloid fibrils and the selective loss of DA (dopamine) containing neurons in the substantia nigra are two key features of PD (Parkinson's disease). α-syn is a natively unfolded protein and adopts an α-helical conformation upon...
Biosci Rep (2007) 27 (1-3): 87–104.
Published: 13 June 2007
... in mitochondria in various tissues of patients with neurodegenerative disorders, the question “is mitochondrial dysfunction a necessary step in neurodegeneration?” is still unanswered. In this review, we highlight some of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic...
Biosci Rep (2006) 26 (5): 341–367.
Published: 09 November 2006
... of the major neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, Amyotrophic lateral sclerosis, Huntington's disease, and prion diseases.) and discuss possible links of gene–environment interplay including, where implicated, mitochondrial genes. © 2006 Springer Science+Business Media, LLC...